Professional Documents
Culture Documents
7MM, Five-Year Diagnosed Prevalent Cases of Brain Cancer, All Ages, Both Sexes, N, 2014 and 2024
89,984
7MM
84,704
46,401
42,104
US
36,148
34,868
5EU
11,038
11,180
Market
Germany
France
8,307
7,929
Japan
7,435
7,732
Italy
6,330
6,044
UK
5,897
5,558
2024
2014
4,576
4,157
Spain
0
20,000
40,000
60,000
80,000
Five-Year Diagnosed Prevalent Cases (N)
Source: GlobalData; Cancer Research UK, 2014b; CCCIS, NCC, 2011; Ferlay et al., 2014; Howlader et al., 2014; ITACAN, 2014; ZfKD, 2014
5EU = France, Germany, Italy, Spain, and UK; 7MM = US, 5EU, and Japan
This report provides an overview of the risk factors, comorbidities, and the global
and historical trends for brain cancer in the seven major markets (7MM) (US,
France, Germany, Italy, Spain, UK, and Japan). In the 7MM, GlobalData
epidemiologists forecast that the diagnosed incident cases of brain cancer will
increase from 55,084 cases in 2014 to 62,226 cases in 2024, at an Annual Growth
Rate (AGR) of 1.30%. The US will have the highest number of diagnosed incident
cases of brain cancer among the 7MM throughout the forecast period. The five-year
diagnosed prevalent cases of brain cancer are also expected to increase from 84,704
cases in 2014 to 89,984 cases in 2024, at an AGR of 0.62%.